Supporting Businesses in the Wake of the COVID-19 Outbreak
Posted in COVID-19, Healthcare
Supporting Businesses in the Wake of the COVID-19 Outbreak

In response to the outbreak of COVID-19, we are closely monitoring guidance issued by local, state and federal authorities, as well as information distributed by the Centers for Disease Control and Prevention and the World Health Organization. We are dedicated to helping clients address business disruptions, anticipate potential challenges and mitigate risk associated with irregular operations. We are available to assist in a number of core areas that may impact public agencies and businesses in this rapidly changing environment. Please visit our COVID-19 Response Team page to read our ongoing coverage of these issues as they evolve.

Here are a few resources that could be particularly helpful for those of you in the healthcare industry:

03.20.2020 | What California Shelter-in-Place and Other Orders Mean for California Employers

03.17.2020 | How to Provide Emergency Credentialing and Privileging for Healthcare Staff to Prepare for Surge in COVID-19 Patients

03.17.2020 | What the Bay Area Shelter in Residence Order Means for Your Healthcare Operations

If you have questions about workforce, regulatory, contractual or other challenges, please contact our COVID-19 Response Team at ResponseTeam@nossaman.com

Twitter Facebook LinkedIn

Our Health Law Ticker is a one-stop resource for everything new and noteworthy in healthcare law.  We cover recent developments in healthcare legislation, healthcare reform, Medicare/Medicaid, managed care, litigation, regulatory compliance, HIPAA, privacy, peer review, medical staffs and general business operations for healthcare companies and licensed healthcare professionals.

Stay Connected

RSS RSS Feed

Categories

Archives

View All Nossaman Blogs
Jump to Page

We use cookies on this website to improve functionality, enhance performance, analyze website traffic and to enable social media features.  To learn more, please see our Privacy Policy and our Terms & Conditions for additional detail.